Canadian Investment Regulatory Organization Trading Halt – SSRM
TORONTO, Feb. 13, 2024 /CNW/ – The following issues have been halted by CIRO: Company: SSR Mining Inc. TSX Symbol: SSRM All Issues: No Reason: Single Stock Circuit Breaker Halt Time (ET): 10:01:10 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a
Canadian Investment Regulatory Organization Trade Resumption – SSRM
TORONTO, Feb. 13, 2024 /CNW/ – Trading resumes in: Company: SSR Mining Inc. TSX Symbol: SSRM All Issues: No Resumption (ET): 10:06:10 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensu
New England Biolabs® Launches NEBNext® Enzymatic 5hmC-seq Kit, for enzyme-based 5hmC detection at single-base resolution
New bisulfite-free system allows scientists to accurately and sensitively discriminate 5hmC from un-modified cytosine and 5mC from a wide range of DNA inputs, advancing epigenetics research. IPSWICH, Mass., Feb. 13, 2024 /PRNewswire/ — New England Biolabs (NEB®) today announced the launch of
Cameron Vetter Joins New Resources Consulting as AI Practice Director
MILWAUKEE, Feb. 13, 2024 /PRNewswire/ — New Resources Consulting (“NRC”), a pioneering technology and business consulting firm with over two decades of experience transforming organizations, is excited to announce Cameron Vetter as its new AI Practice Director. This appointment und
Newbold Advisors Welcomes Senior Executive Pascal Boillat to Launch New Technology Initiatives in the Financial Services Industry
CLEARWATER, Fla., Feb. 13, 2024 /PRNewswire/ — Newbold Advisors is proud to announce the appointment of Pascal Boillat as an advisor to the Board of Directors and an equity partner, effective immediately. Boillat will focus on driving the company’s efforts to introduce innovative technol
Wasatch Biolabs Launches Proprietary Targeted DNA Methylation Sequencing Service for Researchers and Healthcare Providers
HEBER CITY, Utah, Feb. 13, 2024 /PRNewswire/ — Wasatch Biolabs (WBL), a subsidiary of Renew Biotechnologies and a certified Oxford Nanopore Technologies’ laboratory, launches a proprietary Targeted DNA Methylation Sequencing Service for researchers and clinical service providers. The tec
Dave Amerson and Tyler Binney Add Their Experience Commercializing Disruptive Technologies to Intrinsic Therapeutics’ Board of Directors
WOBURN, Mass., Feb. 13, 2024 /PRNewswire/ — Intrinsic Therapeutics, Inc., the developer of the Barricaid, an FDA approved medical device proven to significantly reduce reherniations and reoperations following lumbar discectomy surgery, today announced the appointment of Dave Amerson and Tyler
INTRODUCING THE CASHMERE COLLECTION, THE FIRST-EVER FRAGRANCE COLLECTION FROM DONNA KARAN NEW YORK
Embracing the Layers of a Woman NEW YORK, Feb. 13, 2024 /PRNewswire/ — THE CONCEPT INTRODUCING THE CASHMERE COLLECTION, THE FIRST-EVER FRAGRANCE COLLECTION FROM DONNA KARAN NEW YORK As a legendary fashion label that has created the ultimate New York lifestyle for nearly 40 years, Donna Karan
Takeda Supports the Canadian IBD Research Consortium’s $1 Million Pioneer Grant for Second Year
Funding to attract and advance Canadian clinical research in inflammatory bowel disease TORONTO, Feb. 13, 2024 /CNW/ – Takeda Canada Inc. (Takeda) is pleased to announce its support of the Canadian Inflammatory Bowel Disease Research Consortium’s (CIRC) $1 million PIONEER Grant in its
Allspring Global Investments’ Annual Retirement Survey Finds “Retirement Readiness Disconnect”
Survey also reveals surprising trends on expected retirement age and the “unretiring” phenomenon CHARLOTTE, N.C., Feb. 13, 2024 /PRNewswire/ — There is a disconnect between financial advisors and retirees and near-retirees on retirement readiness, as shown by the 21st annual Allsp
